References
- Stevenson DK, Sunshine P, Benitz WE. Fetal and neonatal brain injury. Cambridge University Press, 3rd ed. 2005, p 287.
- Kenner C, Lott JW. Comprehensive neonatal care: an interdisciplinary approach. Saunders 2007, p 426.
- Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010;363:2320–2331.
- Jansson LM, Dipietro JA, Velez M, Elko A, Williams E, Milio L, O’Grady K, Jones HE. Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol Teratol 2011;33:240–243.
- Swift RM, Dudley M, DePetrillo P, Camara P, Griffiths W. Altered methadone pharmacokinetics in pregnancy: implications for dosing. J Subst Abuse 1989;1:453–460.
- Jansson LM, Dipietro JA, Velez M, Elko A, Knauer H, Kivlighan KT. Maternal methadone dosing schedule and fetal neurobehaviour. J Matern Fetal Neonatal Med 2009;22:29–35.
- Dombrinski, S. Addiction Treatment Forum (ATforum.com) 2006; Vol 15(1).
- Rothwell PE, Gewirtz JC, Thomas MJ. Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology 2010;35:2579–2589.
- Whittmann BK, Segal S. A comparison of the effects of single- and split-dose methadone administration on the fetus: ultrasound evaluation; Int J of Addictions 1991: 26: 213–218.
- Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M, Murphy DJ. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010;105:2071–2084.